in

7 European countries have stopped AstraZeneca reports of “dangerous” blood clots

by Tyler Durden

Update (0954ET): Iceland becomes the latest European country to suspend AstraZeneca.

  • Iceland has also stopped using the COVID / ASTRAZENECA vaccine

The small island nation has confirmed nearly 6,000 cases of coronavirus since the start of the pandemic, roughly 2% of the population.

Back on the continent, the EMA (European equivalent to the Food and Drug Administration) confirmed that it counted at least 30 cases of harmful blood clots in patients who received the vaccine, including at least one case in Denmark where the patient died.

Update (0820ET): More countries have followed Denmark by suspending approval of the AstraZeneca-Oxford COVID vaccine. Norway, Denmark, Estonia, Lithuania, Luxembourg, Latvia and Italy have now chosen to stop using the vaccine, which has created more problems for the slow vaccine introduction in Europe.

These discontinuations follow incidents of blood clots in recently vaccinated patients. Two incidents have been reported in Austria, although Vienna permits continued use of the vaccine, at least for the time being. Serious cases of blood clots have been reported in Denmark and other countries as well.

Natural and non-toxic products. Up to 50% Off – Everyday (Advertisement)

Writer and skeptic Alex Berenson noted in a tweet that an AZ shot with the vaccine is not the only shot of COVID suspected of causing harmful side effects in a small number of patients.

In a tweet confirming the comment, the Danish Minister of Health said that there is currently no way to know whether the cases of serious blood clots are related to the vaccine, but the situation definitely warrants an investigation of the raw materials. He said: “We acted early, and there must be a thorough investigation.”

Just days ago, Italian Prime Minister Mario Draghi stopped a shipment of AstraZeneca bullets to Australia, the first time the EU leader has resorted to the rules to prioritize access to a domestic vaccine. Now, Italian authorities are suspending vaccinations from an existing AstraZeneca vaccine batch after a pair of suspicious deaths.

Meanwhile, health authorities in Brussels and London have rejected these concerns, insisting that the A to Z vaccine is safe, with plans to go ahead with plans to approve a single dose of Johnson & Johnson.

The European Union Medicines Regulatory Authority said it recommended licensing the vaccine to all adults over the age of 18 “after a thorough evaluation” of JNJ’s data found that the vaccine met the criteria for efficacy, safety and quality. JNJ jab is the fourth one to be licensed for use within the European Union.

* * *

The launch of the highly criticized vaccine in Europe faced another obstacle, as Danish health authorities became increasingly concerned about the harmful side effects believed to be linked to the dose of AstraZeneca-Oxford, the cheap COVID treatment that was supposed to help Europe catch up with the United States. And the United Kingdom and Israel.

Danish authorities Thursday temporarily halted AstraZeneca’s COVID-19 shooting after reports of dangerous blood clots inside patients, including one incident that occurred in Denmark. Authorities haven’t specified exactly how many reports of blood clots, but Reuters reports said Austria also stopped using a batch of AstraZeneca shots while investigating a death attributed to a coagulation disorder, along with a disease attributable to pulmonary embolism, a condition in which one or more blockages occur. Lung arteries due to a blood clot. Six other European countries have reportedly stopped distributing the Coronavirus vaccine.

“We and the Danish Medicines Agency must respond to reports of potentially dangerous side effects, whether from Denmark or from other European countries,” Søren Bröstrom, director of the Danish Health Authority, said in a statement.

The Danish Medicines Agency said the suspension would last for 14 days as the authorities start an investigation into blood clots, with the help of other European Union member states.

They did not say how many reports of blood clots, but Austria stopped using a batch of AstraZeneca shots while investigating deaths from blood clotting disorders and obstructive pulmonary disease.

AstraZeneca claims that its vaccine is subject to strict and stringent quality controls and that “there have been no confirmed adverse events associated with the vaccine.” She said she was in contact with the Austrian authorities and would fully support her investigation.

“We and the Danish Medicines Agency must respond to reports of potentially dangerous side effects, whether from Denmark or from other European countries,” said Soren Bröström, director of the Danish Health Authority. “It is important to emphasize that we have not chosen not to use the AstraZeneca vaccine, but we are suspending it.”

The European Medicines Agency said, Wednesday, that there is no evidence linking AstraZeneca to two cases of blood clots in Austria. The company said the number of “thromboembolic events” (forming blood clots) in people who received the AstraZeneca vaccine is no higher than the number seen in the general population, as 22 of these events were reported among the 3 million people who received the vaccine. As of March 9 .

At least one investor claimed that Denmark’s suspension of AstraZeneca’s COVID vaccine due to blood clotting concerns shows that “detection systems looking for potential safety issues are working”, and that most of these “safety events” will ultimately be related to normal processes, not a blow to the elbow.

“It’s good to see security signal detection systems in action and it’s important to track any safety signal using the correct protocols,” Adam Parker, analyst at Shore told Bloomberg. He said that the data derived from the trials of the third phase of the vaccine indicate, “You expect that most of the safety signs will not ultimately be related to the vaccine.”

However, “it is difficult to make judgments about the impact on shareholder value,” he added, given that there are “so many moving parts”. Ultimately, however, risk-reward trade-offs with any treatment. “You can only make judgments on this decision with confidence when all data are completed and clear.”

However, AZ stocks declined on Thursday amid signs that the European vaccine launch faces fresh doubts and hurdles. Shares are down more than 2% in mid-morning London trade.

It remains to be seen whether Austria and other European Union countries follow suit, although at least another national health authority is considering a moratorium: The Norwegian Institute of Public Health and the Medicines Agency are meeting to discuss Denmark’s decision to stop vaccinations with doses of the vaccine, according to state radio reports. NRK.

Source: Zero hedge

Top image: Wake up times


What do you think?

Written by Joseph

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

The best new running shoes for faster and longer runs

Mousse Le Seine enriched with chocolate | Fatgirlskinny.net